July 22nd, 2022
Two of our associates - LiMM Therapeutics and BSIM Therapeutics - were considered two of the most promising biotech companies in Portugal by Labiotech.eu 

For more info: https://www.labiotech.eu/best-biotech/biotech-portugal-companies/

Subscribe
Sign up with your email address to receive news and updates.
Subscription Form

By subscribing to receive news and updates you are automatically agreeing with our Terms & Conditions and Privacy Policy.
Latest news

TransBioNet: Nearly €2 Million Horizon Europe Project to Bring Biomedical Research Closer to Investment Readiness

TransBioNet, a new initiative funded by the European Union’s Horizon Europe programme, has been launched to help promising biomedical research […]
Read more

Leading from Within: AccelBio Team Completes a Leadership Workshop

From October 12th to 14th, 2026, the AccelBio team stepped away from the lab and the office for a three-day […]
Read more

Knowledge Valorisation in Action: AccelBio at the REA Workshop in Brussels

AccelBio’s CEO, Bárbara Gomes, attended the workshop “Knowledge Valorisation in Action: from Results to Policy” on October 8th, 2026, at […]
Read more
1 2 3 … 18
Posted on
September 9, 2021
Author
Co-Lab AccelBio

Contact Us

geral@accelbio.pt+351 918 439 722
Call to national mobile network
Laboratório Colaborativo AccelBio
Biocant Park,
Parque Tecnológico de Cantanhede,
3060-197 Cantanhede
2026 Co-Lab AccelBio All rights reserved ©
|
Designed and built by BOTODACRUZ